Perioperative Duloxetine for Persistent Postoperative Pain After Total Hip Arthroplasty: A Randomized Controlled Trial
The Journal of Arthroplasty · 2026-11
DOI: 10.1016/j.arth.2026.11.017 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Arthroplasty, 2026-11. Verfasst von Masanori Nishi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan. Electronic address: ds110646@med.s…. Die Arbeit nennt 31 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
BACKGROUND: Chronic postsurgical pain (CPSP) persists in 10 to 15% of patients after total hip arthroplasty (THA). Duloxetine provides short-term analgesic benefits, but its role in preventing CPSP remains unclear. This study evaluated whether extended perioperative duloxetine reduced CPSP at three months after THA. METHODS: In this prospective, single-center, open-label, randomized controlled trial, patients undergoing primary THA for osteoarthritis were randomized 1:1 to duloxetine plus standard care or standard care alone. Duloxetine was administered for 12 weeks, with preoperative titration to 60 mg/day, perioperative maintenance, and postoperative tapering. The primary outcome was daily average hip pain at three months, assessed using a numerical rating scale (NRS); CPSP was defined as a score ≥ 3. The secondary outcomes included the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JHEQ) score, Merle d'Aubigné-Postel (DAP) score, and postoperative analgesic consumption. There were 96 patients who underwent THA (duloxetine, n = 47; control, n = 49). RESULTS: At three months, the median pain NRS score was 0 (interquartile range, 0 to 1) in both groups (P = 0.17), and CPSP incidence was 6.4 and 10.2%, respectively (P = 0.72). Functional outcomes favored the duloxetine group, with higher total JHEQ scores (driven by movement and mental domains) and improved DAP pain and mobility domain scores. Celecoxib consumption was lower in the duloxetine group at one and three months (P < 0.05). Duloxetine was discontinued in 21% of patients because of adverse events; none were serious. CONCLUSION: Perioperative duloxetine did not reduce pain or CPSP incidence at three months after THA. Nevertheless, improved functional outcomes and lower analgesic use suggest a potential role in enhancing postoperative recovery. Routine use is not supported, although some patients may benefit.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan. Electronic address: ds110646@med.showa-u.ac.jp.
- Department of Orthopaedic Surgery, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
- Research Administration Center, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
- Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Japan, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
- Division of Pharmacotherapeutics, Department of Clinical Pharmacy, School of Pharmacy, Showa Medical University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Zitieren
APA
Nishi, M., Yoshikawa, Y., Usui, Y., Inoue, E., Nakamura, S., Nishida, H., Ida, H., Tashiro, K., Kurihara, T., Kogo, M., & Kudo, Y. (2026). Perioperative Duloxetine for Persistent Postoperative Pain After Total Hip Arthroplasty: A Randomized Controlled Trial. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2026.11.017
Vancouver
Nishi M, Yoshikawa Y, Usui Y, Inoue E, Nakamura S, Nishida H, et al. Perioperative Duloxetine for Persistent Postoperative Pain After Total Hip Arthroplasty: A Randomized Controlled Trial. The Journal of Arthroplasty. 2026. doi:10.1016/j.arth.2026.11.017
BibTeX
@article{Nishi2026,
author = {Nishi, Masanori and Yoshikawa, Yasushi and Usui, Yuki and Inoue, Eisuke and Nakamura, Shota and Nishida, Hajime and Ida, Hiroshi and Tashiro, Koichiro and Kurihara, Tatsuya and Kogo, Mari and Kudo, Yoshifumi},
title = {Perioperative Duloxetine for Persistent Postoperative Pain After Total Hip Arthroplasty: A Randomized Controlled Trial},
journal = {The Journal of Arthroplasty},
year = {2026},
doi = {10.1016/j.arth.2026.11.017}
}
EUVIMED